AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells

Molecular Pharmacology

Volumn 81, Issue 3, 2012, Pages 299-308

  Kaushal, Nidhi ^a   Elliott, Meenal ^a   Robson, Matthew J ^a   Iyer, Anand Krishnan V ^a,c   Rojanasakul, Yon ^a   Coop, Andrew ^b   Matsumoto, Rae R ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c HAMPTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLOROMETHYL 2',7' DICHLORODIHYDROFLUORESCIN DIACETATE; 6 CHLOROMETHYL 2',7' DICHLORODIHYDROFLUORESCIN DIACETATE; AC 927; ACETOACETIC ACID; ACETYL ESTER; ACETYLCYSTEINE; CATALASE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE TRANSPORTER; ESTER DERIVATIVE; HYDROGEN PEROXIDE; MESSENGER RNA; METHAMPHETAMINE; N(G) METHYLARGININE; NORADRENALIN TRANSPORTER; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SEROTONIN TRANSPORTER; SIGMA 1 OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CULTURE MEDIUM; CYTOTOXICITY; DOPAMINE RELEASE; DRUG MECHANISM; NECROSIS; NEUROPROTECTION; PRIORITY JOURNAL;

APOPTOSIS; CELL LINE, TUMOR; DOPAMINE; FLOW CYTOMETRY; HUMANS; METHAMPHETAMINE; OXALIC ACIDS; PIPERIDINES; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, SIGMA; TYROSINE 3-MONOOXYGENASE;

EID: 84857407923     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.074120     Document Type: Article

References (41)

1. Azad N, Iyer AK, Manosroi A, Wang L, and Rojanasakul Y (2008) Superoxide-mediated proteasomal degradation of Bcl-2 determines cell susceptibility to Cr(VI)-induced apoptosis. Carcinogenesis 29:1538-1545.
2. Booth RG and Baldessarini RJ (1991) (+)-6,7-Benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res 557:349-352.
3. Bowen WD (2000) Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv 74:211-218.
4. Cadet JL and Brannock C (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117-131. (Pubitemid 28105298)
5. Cadet JL, Ordonez SV, and Ordonez JV (1997) Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 25:176-184. (Pubitemid 27121228)
6. Cañete E and Diogène J (2008) Comparative study of the use of neuroblastoma cells (Neuro-2a) and neuroblastomaxglioma hybrid cells (NG108-15) for the toxic effect quantification of marine toxins. Toxicon 52:541-550.
7. 2 Receptors regulate changes in sphingolipid levels in breast tumor cells. Eur J Pharmacol 443:207-209.
8. DeCoster MA, Klette KL, Knight ES, and Tortella FC (1995) Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures. Brain Res 671:45-53.
9. 2-receptor regulation of dopamine transporter via activation of protein kinase C. J Pharmacol Exp Ther 301:306- 314.
10. Ghahary A, Vriend J, and Cheng KW (1989) Modification of the indolamine content in neuroblastoma X glioma hybrid NG108-15 cells upon induced differentiation. Cell Mol Neurobiol 9:343-355. (Pubitemid 19250318)
11. 3H]dopamine release from rat striatal slices by sigma receptor ligands. J Pharmacol Exp Ther 271:212- 219.
12. Guitart X, Codony X, and Monroy X (2004) Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl) 174:301-319. (Pubitemid 39044288)
13. Hall AA, Herrera Y, Ajmo CT Jr, Cuevas J, and Pennypacker KR (2009) Sigma receptors suppress multiple aspects of microglial activation. Glia 57:744-754.
14. Han DD and Gu HH (2006) Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6:6.
15. 1 binding sites) in NG108-15 cells. J Pharmacol Exp Ther 306:726-733.
16. 2+ signaling and cell survival. Cell 131:596-610.
17. Higuchi M, Honda T, Proske RJ, and Yeh ET (1998) Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 17:2753-2760. (Pubitemid 28554234)
18. Jayanthi S, Deng X, Ladenheim B, McCoy MT, Cluster A, Cai NS, and Cadet JL (2005) Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci USA 102:868-873. (Pubitemid 40282757)
19. Kekuda R, Prasad PD, Fei YJ, Leibach FH, and Ganapathy V (1996) Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun 229:553-558. (Pubitemid 27029069)
20. Krasnova IN and Cadet JL (2009) Methamphetamine toxicity and messengers of death. Brain Res Rev 60:379-407.
21. Ma W, Pancrazio JJ, Coulombe M, Dumm J, Sathanoori R, Barker JL, Kowtha VC, Stenger DA, and Hickman JJ (1998) Neuronal and glial epitopes and transmitter-synthesizing enzymes appear in parallel with membrane excitability during neuroblastoma X glioma hybrid differentiation. Brain Res Dev Brain Res 106:155-163. (Pubitemid 28168481)
22. Maeda DY, Williams W, Kim WE, Thatcher LN, Bowen WD, and Coop A (2002) N-arylalkylpiperidine as high-affinity sigma-1 and sigma-2 receptor ligands: phenylpropylamines as potential leads for selective sigma-2 agents. Bioorg Med Chem Lett 12:497-500. (Pubitemid 34113932)
23. Marrazzo A, Fiorito J, Zappalà L, Prezzavento O, Ronsisvalle S, Pasquinucci L, Scoto GM, Bernardini R, and Ronsisvalle G (2011) Antiproliferative activity of phenylbutyrate ester of haloperidol metabolite II [(±)-MRJF4] in prostate cancer cells. Eur J Med Chem 46:433-438.
24. Matsumoto RR, Shaikh J, Wilson LL, Vedam S, and Coop A (2008) Attenuation of methamphetamine-induced effects through the antagonism of sigma (σ) receptors: evidence from in vivo and in vitro studies. Eur Neuropsychopharmacol 18:871- 881.
25. McCann DJ, Weissman AD, and Su TP (1994) Sigma-1 and sigma-2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns. Synapse 17:182- 189.
26. Melega WP, Jorgensen MJ, Laćan G, Way BM, Pham J, Morton G, Cho AK, and Fairbanks LA (2008) Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles. Neuropsychopharmacology 33:1441-1452. (Pubitemid 351521710)
27. Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortés A, Casadó V, Canela EI, Ortiz J, et al. (2010) Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proc Natl Acad Sci USA 107:18676-18681.
28. Nguyen EC, McCracken KA, Liu Y, Pouw B, and Matsumoto RR (2005) Involvement of sigma (σ) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology 49:638-645. (Pubitemid 41208285)
29. O'Brien TJ, Ceryak S, and Patierno SR (2003) Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res 533:3-36. (Pubitemid 37487859)
30. Ostenfeld MS, Fehrenbacher N, Høyer-Hansen M, Thomsen C, Farkas T, and Jäättelä M (2005) Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res 65:8975-8983. (Pubitemid 41377389)
31. Schetz JA, Perez E, Liu R, Chen S, Lee I, and Simpkins JW (2007) A prototypical sigma-1 receptor antagonist protects against brain ischemia. Brain Res 1181:1-9. (Pubitemid 350050910)
32. Schmidt CJ and Lovenberg W (1985) In vitro demonstration of dopamine uptake by neostriatal serotonergic neurons of the rat. Neurosci Lett 59:9-14. (Pubitemid 15017342)
33. Seminerio MJ, Kaushal N, Shaikh J, Huber JD, Coop A, and Matsumoto RR (2011) Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice. Pharmacol Biochem Behav 98:12-20.
34. Su TP, Hayashi T, Maurice T, Buch S, and RuohoAE(2010) The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci 31:557-566.
35. Tsai SY, Hayashi T, Mori T, and Su TP (2009) Sigma-1 receptor chaperones and diseases. Cent Nerv Syst Agents Med Chem 9:184-189.
36. Vilner BJ and Bowen WD (2000) Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. J Pharmacol Exp Ther 292:900-911. (Pubitemid 30136581)
37. Vilner BJ, John CS, and Bowen WD (1995) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 55:408-413.
38. Wheeler KT, Wang LM, Wallen CA, Childers SR, Cline JM, Keng PC, and Mach RH (2000) Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br J Cancer 82:1223-1232. (Pubitemid 30128883)
39. Wu CW, Ping YH, Yen JC, Chang CY, Wang SF, Yeh CL, Chi CW, and Lee HC (2007) Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol Appl Pharmacol 220:243-251.
40. Yang ZJ, Carter EL, Torbey MT, Martin LJ, and Koehler RC (2010) Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/ postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neurons. Exp Neurol 221:166-174.
41. Zeng C, Vangveravong S, Xu J, Chang KC, Hotchkiss RS, Wheeler KT, Shen D, Zhuang ZP, Kung HF, and Mach RH (2007) Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. Cancer Res 67:6708-6716. (Pubitemid 47105517)